Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 20, 2011BloodOpen Access

Normalization of pre-ASCT, FDG-PET imaging with second-line, non–cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

CMCraig H. MoskowitzMMMatthew J. MatasarAZAndrew D. Zelenetz

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Moskowitz et al. (2011) studied this question.

synapsesocial.com/papers/69ffc679b124fe5819859cf1https://doi.org/10.1182/blood-2011-10-388058
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1How I treat relapsed and refractory Hodgkin lymphoma2011 · 143 citations
  2. 2A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model2001 · 428 citations
  3. 3Long-Term Effects of High-Dose Chemotherapy and Radiation for Relapsed and Refractory Hodgkin's Lymphoma2008 · 73 citations
  4. 4High‐dose chemo‐radiotherapy for relapsed or refractory Hodgkin lymphoma and the significance of pre‐transplant functional imaging2010 · 93 citations
  5. 5Effectiveness of high dose chemoradiotherapy and autologous stem cell transplantation for patients with biopsy‐proven primary refractory Hodgkin's disease2004 · 170 citations